Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naive HIV: A one-year prospective study

被引:4
作者
Martinez-Ayala, Pedro [1 ]
Alanis-Sanchez, Guillermo Adrian [2 ]
Alvarez-Zavala, Monserrat [3 ]
Sanchez-Reyes, Karina [3 ]
Ruiz-Herrera, Vida Veronica [1 ]
Cabrera-Silva, Rodolfo Ismael [3 ]
Gonzalez-Hernandez, Luz Alicia [1 ,3 ]
Ramos-Becerra, Carlos [2 ]
Cardona-Munoz, Ernesto [2 ]
Andrade-Villanueva, Jaime Federico [1 ,3 ]
机构
[1] Univ Guadalajara, Univ Hosp Fray Antonio Alcalde, HIV Unit Dept, Guadalajara, Mexico
[2] Univ Guadalajara, Dept Physiol, Arterial Stiffness Lab, Guadalajara, Mexico
[3] Univ Guadalajara, HIV & Immunodeficiencies Res Inst, Clin Med Dept, CUCS, Guadalajara, Mexico
来源
PLOS ONE | 2023年 / 18卷 / 03期
关键词
IMMUNODEFICIENCY-VIRUS-INFECTION; INTERCELLULAR-ADHESION MOLECULE-1; C-REACTIVE PROTEIN; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; AORTIC STIFFNESS; E-SELECTIN; EXPRESSION; INITIATION; DISEASE;
D O I
10.1371/journal.pone.0282728
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
IntroductionCardiovascular disease is a major cause of death among people living with HIV (PLH). Non-treated PLH show increased levels of inflammation and biomarkers of vascular activation, and arterial stiffness as a prognostic cardiovascular disease risk factor. We investigated the effect of one year of ART on treatment-naive HIV(+) individuals on arterial stiffness and inflammatory and vascular cytokines. MethodsWe cross-sectionally compared aortic stiffness via tonometry, inflammatory, and vascular serum cytokines on treatment-naive (n = 20) and HIV (-) (n = 9) matched by age, sex, metabolic profile, and Framingham score. We subsequently followed young, treatment-naive individuals after 1-year of ART and compared aortic stiffness, metabolic profile, and inflammatory and vascular serum biomarkers to baseline. Inflammatory biomarkers included: hs-CRP, D-Dimer, SAA, sCD163s, MCP-1, IL-8, IL-18, MRP8/14. Vascular cytokines included: myoglobin, NGAL, MPO, Cystatin C, ICAM-1, VCAM-1, and MMP9. ResultsTreatment-naive individuals were 34.8 years old, mostly males (95%), and with high smoking prevalence (70%). Baseline T CD4(+) was 512 & PLUSMN;324 cells/mcL. cfPWV was similar between HIV(-) and treatment-naive (6.8 vs 7.3 m/s; p = 0.16) but significantly decreased after ART (-0.52 m/s; 95% CI -0.87 to -0.16; p0.006). Almost all the determined cytokines were significantly higher compared to controls, except for MCP-1, myoglobin, NGAL, cystatin C, and MMP-9. At follow-up, only total cholesterol and triglycerides increased and all inflammatory cytokines significantly decreased. Regarding vascular cytokines, MPO, ICAM-1, and VCAM-1 showed a reduction. D-Dimer tended to decrease (p = 0.06) and hs-CRP did not show a significant reduction (p = 0.17). ConclusionOne year of ART had a positive effect on reducing inflammatory and vascular cytokines and arterial stiffness.
引用
收藏
页数:14
相关论文
共 52 条
  • [1] [Anonymous], GLOB HIV AIDS STAT F
  • [2] DOMINANCE STATISTICS - ORDINAL ANALYSES TO ANSWER ORDINAL QUESTIONS
    CLIFF, N
    [J]. PSYCHOLOGICAL BULLETIN, 1993, 114 (03) : 494 - 509
  • [3] Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
    Croce, Kevin
    Gao, Huiyun
    Wang, Yunmei
    Mooroka, Toshifumi
    Sakuma, Masashi
    Shi, Can
    Sukhova, Galina K.
    Packard, Rene R. S.
    Hogg, Nancy
    Libby, Peter
    Simon, Daniel I.
    [J]. CIRCULATION, 2009, 120 (05) : 427 - U126
  • [4] Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
    Daar, Eric S.
    Tierney, Camlin
    Fischl, Margaret A.
    Sax, Paul E.
    Mollan, Katie
    Budhathoki, Chakra
    Godfrey, Catherine
    Jahed, Nasreen C.
    Myers, Laurie
    Katzenstein, David
    Farajallah, Awny
    Rooney, James F.
    Pappa, Keith A.
    Woodward, William C.
    Patterson, Kristine
    Bolivar, Hector
    Benson, Constance A.
    Collier, Ann C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (07) : 445 - 456
  • [5] Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study
    Di Yacovo, Silvana
    Saumoy, Maria
    Luis Sanchez-Quesada, Jose
    Navarro, Antonio
    Sviridov, Dmitri
    Javaloyas, Manuel
    Vila, Ramon
    Vernet, Anton
    Low, Hann
    Penafiel, Judith
    Garcia, Benito
    Ordonez-Llanos, Jordi
    Podzamczer, Daniel
    [J]. PLOS ONE, 2020, 15 (08):
  • [6] Neutrophil Gelatinase-Associated Lipocalin (NGAL) is Associated with Symptomatic Carotid Atherosclerosis and Drives Pro-inflammatory State In Vitro
    Eilenberg, W.
    Stojkovic, S.
    Piechota-Polanczyk, A.
    Kaun, C.
    Rauscher, S.
    Groeger, M.
    Klinger, M.
    Wojta, J.
    Neumayer, C.
    Huk, I.
    Demyanets, S.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2016, 51 (05) : 623 - 631
  • [7] Potent Antiretroviral Therapy for Human Immunodeficiency Virus Infection Increases Aortic Stiffness
    Eira, Margareth
    Bensenor, Isabela M.
    Dorea, Egidio Lima
    Cunha, Roberto Sa
    Mill, Jose Geraldo
    Lotufo, Paulo A.
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 99 (06) : 1100 - 1107
  • [8] Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults
    El-Bejjani, Dalia
    Hazen, Stanley L.
    Mackay, Wilma
    Glass, Nina E.
    Hulgan, Todd
    Tungsiripat, Marisa
    McComsey, Grace A.
    [J]. HIV CLINICAL TRIALS, 2008, 9 (03): : 207 - 211
  • [9] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    SHIGENAGA, JK
    JENSEN, P
    FEINGOLD, KR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1045 - 1052
  • [10] Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction
    Gunnett, CA
    Lund, DD
    McDowell, AK
    Faraci, FM
    Heistad, DD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 1617 - 1622